Corrigendum to "Pin1 inhibition reverses the acquired resistance of human hepatocellular carcinoma cells to Regorafenib via the Gli1/Snail/E-cadherin pathway" [Cancer Lett. 444 (2019) 82-93].
Cancer letters
| Authors | |
| Year of Publication | 2024
|
| Journal | Cancer letters
|
| Pages | 217257
|
| Date Published | 09/2024
|
| ISSN | 1872-7980
|
| DOI | 10.1016/j.canlet.2024.217257
|
| PubMed ID | 39333006
|
| Links |